Features Pricing Learn Reverse Splits Tracker Shelf & ATM Tracker Warrant Tracker PIPE Deal Tracker Weekly Report FAQ API Sign In →
59 /100
HIGH RISK
Score updated Oct 13, 2026

ALLR — Allarity Therapeutics, Inc. Dilution Risk Tracker

Track ALLR dilution risk with DilutionWatch's stock tracker. DilutionScore™ measures dilution risk across 5 factors — lower scores indicate higher risk of share dilution.

⚠️ Not financial advice. Do your own research before making any investment decisions.

🔔 Track ALLR — Get alerts when the score changes →

As of October 13, 2026, Allarity Therapeutics, Inc. (ALLR) has a DilutionWatch DilutionScore of 59/100, rated HIGH dilution risk. Allarity Therapeutics, Inc. has a market capitalization of $15.75M, 15.91M shares outstanding. Stored dilution-related fields include shelf registration capacity of $6.00M, ATM program capacity of $6.00M, 829.4K outstanding warrants.

This page includes automatically generated factual summaries from DilutionWatch data. It is not financial advice, not investment research, and not a recommendation. Do your own research. Read the full disclaimer and terms of service.

Score Breakdown

📋 Offering Ability
80
💰 Cash Runway
40
📊 Float Risk
12
⚠️ Warrant Exposure
30
🔄 Convertible Debt
35

Dilution Forecast

⛅
Watch
Minor dilution signals detected
model est. 31%
💰 Capital Raise model 38%
• Active shelf registration ($6M, 38% of market cap)
• Active ATM program with $6M remaining capacity
🔄 Reverse Split model est. 30%
• 50-day avg $1.34 approaching $1 threshold
📜 Warrant Exercise model 15%
• Warrant overhang: 5.2% of shares outstanding
🔔 Track ALLR — Get forecast alerts →

Market Data

Market Cap$15.75M
Shares Outstanding15.91M
Float15.74M
Cash$16.98M
Debt$2.94M
Short InterestN/A

Source-Backed Evidence Depth

This public preview uses stored DilutionWatch fields and linked SEC/market records only. Missing values are not estimated.

FieldCurrent ValueBasis
DilutionScore59/100DilutionWatch score record
Shares Outstanding15.91MVerified float table or market cache
Public Float15.74MVerified float table or market cache
Market Cap$15.75MMarket data cache
Cash Runway17.2 monthsDilutionWatch score inputs
Shelf Capacity$6.00MSEC-derived dilution fields
ATM Capacity$6.00MSEC-derived dilution fields
Outstanding Warrants829.4KSEC-derived dilution fields

Recent source-backed SEC insight records available on this page: 7.

Recent SEC source mix: 424B3 1, 8-K 1, EFFECT 1, S-3 1, S-3/A 1, XBRL 2.

The page does not infer future share issuance, financing probability, cash needs, management intent, or price impact when source fields are absent.

Institutional Holdings

8.1% institutional ownership
Source: Yahoo Finance · Detailed 13F holder data available for tracked tickers
🔔 Track ALLR for full holder detail →

Short Interest

Short Interest119.2K
Days to Cover1.0
% of Float0.8%
FINRA data as of Sep 30, 2026

Recent SEC Activity

xbrl XBRL CONVERTIBLE 2026-03-30
xbrl XBRL WARRANT 2025-03-31
424B3 ATM 2026-04-27
S-3/A SHELF 2026-04-24
EFFECT EFFECT 2026-04-24
Full SEC filing analysis available with free account →

Recent News

No recent news available for this ticker.

Factual ALLR Dilution Snapshot

Allarity Therapeutics, Inc. (ALLR) has a DilutionScore of 59/100, rated High dilution risk. Score date: October 13, 2026.

This automatically generated snapshot is assembled from stored DilutionWatch data fields and may contain data-source errors or omissions. It is not financial advice, not investment research, and not a recommendation. Do your own research and review the full disclaimer and terms of service.

DilutionScore History — Last 90 Days

ALLR's DilutionScore is currently 59/100 (High risk), with 2 score changes tracked over 89 days. The score improved from 56/100 (High risk).

Period Score Risk Level Duration
Oct 01 – Oct 13, 202659/100HIGH13 days
Aug 14 – Sep 30, 202656/100HIGH47 days
Jul 16 – Aug 13, 202651/100HIGH29 days

Score recalculated daily from SEC filings and market data. Sign up free for real-time score change alerts.

Share Dilution History

ALLR shares outstanding have decreased 3.9% from 16.08M (Apr 2026) to 15.46M (May 2026). Each increase represents potential dilution to existing shareholders.

Date Shares Outstanding Public Float Change
May 09, 202615.46M15.74M▼ 0.32%
Apr 01, 202616.08M15.79M▲ 0.04%

Share counts sourced from verified regulatory filings. Increases indicate dilution events.

Track ALLR Dilution Risk in Real-Time
DilutionWatch monitors SEC filings 24/7 and alerts you the moment ALLR files a shelf registration, ATM offering, warrant notice, or convertible note. Free tier available — no credit card required.
Start Tracking ALLR — Free
Email alert within minutes of any SEC filing Daily DilutionScore™ recalculation Score history & trend tracking Tracks 8,000+ tickers simultaneously

Related Stocks — HIGH Risk

Other HIGH dilution risk stocks tracked by DilutionWatch with similar profiles:

→ Biotech / Pharma sector dilution risk overview

Browse all 8,490+ tracked stocks →

📖 Dilution Education
→ Complete Dilution Guide for Retail Investors → Anti-Dilution Provisions Explained → Stock Dilution Red Flags to Watch → Understanding Shelf Registrations
More Research for ALLR
ALLR FDA Catalyst Timeline & Biotech Grade — BiotechSigns

Part of the Guerilla Finance research network. Cross-reference multiple data sources for better due diligence.